Purchase order for the establishment of high throughput sars-COV-2 neutralizing antibody immunoassay capability and testing of human serum samples
Ended Purchase Order Awarded Last action
- Contract number
- 75A50121P00003
- Awardee
-
Monogram Biosciences, Inc. UEI LFM3XDVK31M7 Part of Laboratory Corporation Of America Holdings
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $5,166,413
Award facts
- Opportunity
-
- 75A50120R00053 Solicitation number
- Establishment of high throughput SARS-CoV-2 neutralizing antibody immunoassay capability and testing of human serum samples Limited / Sole Source Justification · Posted Oct 27, 2020
- Establishment of high throughput SARS-CoV-2 neutralizing antibody immunoassay capability and testing of human serum samples Award Notice · Posted Oct 27, 2020
- Contract value 74% obligated
-
- $5,166,413.00 Current, with exercised options
- $6,960,913.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- South San Francisco, CA 94080, USA
- National interest action
- Coronavirus COVID-19
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | -$165,227 | |
| Change Order | $727,600 | |
| Exercise an Option | $3,524,940 | |
| Exercise an Option | $691,600 | |
| Change Order | -$22,500 | |
| Original award | $410,000 |
About this award
This purchase order, valued at $6.96 million, was awarded by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response to Monogram Biosciences, Inc. to establish high-throughput SARS-CoV-2 neutralizing antibody immunoassay capability and test human serum samples. As a subsidiary of Laboratory Corporation of America Holdings, Monogram will perform this work establishing a testing capability and analyzing samples at its facility in South San Francisco, California over the one-year base period of performance from October 2020 to October 2021 under a firm fixed price contract. The funding supports the agency's efforts to respond to the Coronavirus Disease 2019 pandemic by expanding serological testing capacity and analyzing serum samples to detect the presence of SARS-CoV-2 neutralizing antibodies.
Quick answers
Who was awarded contract 75A50121P00003?
75A50121P00003 was awarded to Monogram Biosciences, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on October 26, 2020.
How much is contract 75A50121P00003 worth?
The government has obligated $5,166,413 on 75A50121P00003. Its potential value, with all options, is $6,960,913.
Was contract 75A50121P00003 competed?
The extent of competition for 75A50121P00003 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award